Jennifer Lawson

Jennifer Lawson — From Naïve to Decisive: My 10-Year Journey in Trading My name is Jennifer Lawson. Ten years ago, I knew nothing about the stock market. I was just an ordinary girl who believed that saving money in the bank was the only way to feel “safe.” Then one day, I watched my savings shrink while inflation kept rising. That was the first time I realized — not making decisions is also a decision. I started reading everything I could about investing: books, news, company reports, even old Warren Buffett letters. I made mistakes. A lot of them. I bought at highs, sold at lows, chased the noise, and blamed the market every time I lost. But slowly, I changed. I learned that trading isn’t about predicting the future — it’s about managing yourself. Discipline over emotion. Logic over fear. I began to think differently — not just as an investor, but as a strategist. I studied global markets, currency volatility, and cross-border capital flows. I built my own models, learned to read between the numbers, and found calm in chaos. Today, I trade full-time. I’m no longer that naïve girl who feared losses. I’m cool-headed, analytical, and decisive — shaped by every mistake I once made. Ten years ago, I was chasing luck. Now, I build strategy. And that’s how I found freedom — not just financial, but mental.

$LULU closed around $187 today, down about 0.3% on the day. After hours, it was instantly pushed above $200 (+7.06%) — a clear sign that the market suddenly turned optimistic about its upcoming earnings.

$NBIS tapped $94 today — classic “wants to run but hesitates, wants to drop but refuses” price action. Enterprise AI is in full-on arms race mode, yet $NBIS is acting like it’s waiting for someone to light the fuse. Let’s be blunt: everything comes down to the $92 line of life and death: 🟢 Holds $92 → snaps back toward $98–100, and it moves fast when it does 🔴 Loses $92 → likely flushes to $87 for a full psychological reset And don’t forget — this is the AI cloud sector: When it takes off, it’s a rocket; when it pulls back, it’s a cliff dive. Trading $NBIS doesn’t require perfect technique. But your risk tolerance better be stronger than everyone else’s.

$IREN got slammed down to $44, but the market is just scaring itself. The core thesis hasn’t changed: Microsoft partnership solid, compute cycle strong, demand still exploding. Dip? That’s just reload time for the brave. Watch $42 short-term. If it holds, next stop is still $50; If it breaks, let it flush sentiment before the next move up. Trading $IREN requires a strong heart , this is a high-beta AI name. You’re not here for small gains.

$NVDA pulled back to the $184 range today, but the news flow is anything but quiet: CoreWeave just dropped another $6.3B order, and the demand for AI compute is only getting stronger. Meanwhile, the U.S. suddenly eased H200 exports to China — adding a 25% fee while still wanting to sell chips. It’s giving serious “scolding while doing business” vibes 🤣 As long as $NVDA holds the $180 support, a move toward $190–195 is still on the table; but policy risk is all over the place right now, so anyone trading $NVDA better have a strong stomach.

$GOOGL pulled back from 330 to around 312, mainly because the EU suddenly launched an antitrust probe, claiming Google may have improperly used publisher content to train its AI… spooking the market a bit 😂 But the ad business is still solid, and Gemini is upgrading fast. As long as $308–312 holds, this is likely just a strong pullback in an ongoing uptrend. A short-term move back to $320–330 is very possible; but if the EU really drops a fine, the stock might take another hit.

$ASTS just shot back up to $74 — with the S2–S3B funding secured and the BlueBird satellite network about to accelerate, market sentiment lit up instantly. $ASTS is the definition of a high-beta play: it explodes on any news, but don’t forget it’s still unprofitable, and future satellite deployments, carrier partnerships, and commercialization progress are all big variables. If you love high-risk, high-reward bets on the future, keep an eye on it; if you’re a conservative investor, don’t overweight — this thing pumps hard and pulls back just as hard.

$META recently rebounded +1.8%, hitting around $673, with AI and advertising growth expectations boosting market sentiment. Metaverse investments continue, but the main support for the stock is Meta’s AI monetization and ad revenue. A short-term break above $680 could target $700, though high valuations mean there’s also downside risk. If you like tech growth stocks and believe in AI, keep an eye on it; for conservative investors, don’t overweight — $META is a high-volatility asset.

If you are a long-term investor with confidence in the future of technology/AI/big tech companies and are not averse to volatility, $QQQ is a "low-maintenance, high-liquidity, high-potential return" basket. Over the next 5-10 years, it could deliver solid returns. If you prefer to avoid volatility or are concerned about overexposure to a single tech sector, $QQQ may not be the best choice. Instead, a broader diversified or low-volatility/high-dividend strategy might suit you better. For medium-term investors looking to balance risk/reward, a mix of $QQQ with some defensive/value/non-tech positions might be a reasonable approach.

This Week's Market Highlights: Tech Stocks Remain Strong, Market Volatility Increases 🔹 AI & Semiconductors in the Spotlight: $NVDA & $AMD continue to benefit from the AI boom, but high valuations and macro uncertainty may pose risks. 🔹 Stable Blue Chips: $AAPL & $MSFT show steady performance, suitable for defensive strategies, but may be overshadowed by the "growth stock" hype in the short term. 🔹 $TSLA Experiences Increased Volatility: Strong prospects for electric vehicles and autonomous driving, but short-term uncertainty due to policy changes and consumer sentiment. 🔹 Market Sentiment Diverges: Tech stocks are rebounding strongly, but high valuations remain a risk. Outlook for Next Week: Accelerating capital flows, with market expectations for AI prospects and interest rate policies likely driving the trend.

The current market still has low tolerance for tech, large-cap growth, new-economy names, high valuations, and high growth expectations — short-term volatility and risk remain elevated. Among these stocks, $GOOGL and $AMZN lean more toward stability + long-term value + diversified business support; while $MDB, $NVO, $SOFI, $HOOD fall into the category of high risk, high volatility, and high-expectation/high-beta plays. If you prefer steady growth, focus on $GOOGL / $AMZN. If you’re willing to take higher risk for potentially higher returns — and can tolerate pullbacks — then $MDB / $NVO / $SOFI / $HOOD may fit your style. but be sure to diversify and use stop-loss strategies.

The market clearly hasn’t caught on yet: The FDA is set to deliver a key ruling this month on $NVO ’s oral Wegovy, with Phase III data already completed. If approved, $NVO will become the first company in the world to successfully launch an oral GLP-1 treatment. This isn’t just another drug — it’s a rewrite of the entire obesity-treatment landscape.

@TrendSpider The pre-market gain of +5% is promising, but whether it can hold above the breakout range is key. Today's closing price is crucial.

$ALAB picking up right where it left off. 🟩 +5% pre-market

@Mr_Derivatives Burry is adept at predicting macroeconomic black swan events, but the certainty in the AI ​​sector is stronger than he imagined. Different perspectives drive market activity.

Michael Burry is now short $NVDA, $PLTR, and $TSLA. Here we go again… Big Short 2.0 movie in the works? Or another mishap “Sell” type tweet that will continue to plague him? 🤔

@wallstengine Postponing penalties offers some respite, but FCF guidance remains weak. The core issue remains execution and delivery capabilities.

BOEING $BA SEES DOJ PENALTY TO FLIP INTO 2026... SEES $2 BILLION FREE CASH OUTFLOW FOR 2025... SEES LOW SINGLE DIGIT FCF IN 2026

$MDB up +23% pre-market → $406. Price target raised from $365 → $480, igniting the entire AI data sector. Flat yesterday, leading today.

According to the latest industry channels, Samsung’s expansion in the second half of this year is far more aggressive than expected: Through $AVGO, Samsung has already secured 60%+ of the HBM capacity required for $GOOGL ’s TPU, and is positioned to remain a primary supplier through 2026. At the same time, Samsung has begun delivering 36GB HBM4 samples with 3.3 TB/s bandwidth, pushing performance to the cutting edge. SK Hynix is targeting large-scale HBM4 production after Q2 2026, while Micron $MU currently holds only about one-third of South Korea’s HBM wafer capacity — signaling a major reshuffle in the market landscape.

Looking back after the close, these five popular stocks have each walked into completely different destinies: $NFLX closed around $108 — a rebound, yes, but subscriber growth vs. content spending is still a constant tug-of-war. 📈 Strong breakout: target $130 📉 If consumer demand weakens: $95 comes fast $SOFI keeps swinging in the $29–30 range. The Fintech narrative is loud, but so are its valuation and volatility. 📈 Smooth momentum: $35–38 📉 If regulation or rates tighten: $22–25 $HOOD closed near $123, moving almost tick-for-tick with BTC. 📈 Crypto rebound: straight to $150–160 📉 Another crypto selloff: drops to $100–110 $NVO pulled back to the $48 zone, as the GLP-1 hype fades and the stock becomes a pure “value vs. risk” debate. 📈 If bulls return: $60–70 📉 If pipeline falters: $40 won’t hold $GOOGL remains the steadiest of the five, but AI + Cloud + Ads is still a triple-pressure setup. 📈 Long-term story stays intact 📉 But if macro turns south, short-term volatility is inevitable Today’s session made one thing very clear: The market doesn’t believe in “guaranteed winners.” Every stock you think is stable carries an equally heavy set of risks.

$NVO isn’t a steady blue-chip — it’s a ticking time bomb in the pharmaceutical world. If the market is still dreaming about “GLP-1 + weight-loss + hyper-growth + perpetual profits,” then it’s massively underestimating the risks: regulatory setbacks, drug-approval failures, pricing pressure, reimbursement risk, and macro funding costs. In this bet, a “blockbuster pipeline” is the ace — but one misstep can take the stock from $80 straight to $30. Are you really ready for that kind of risk?

Strategy $MSTR has finally stopped pretending to be a software company — it’s now just a high-leverage Bitcoin bet. A $1.44B cash buffer, 2025 guidance slashed from +$24B to “-$5.5B to +$6.3B,” mNAV dropping to 1.1, and the CEO even talking about “selling BTC if necessary.” The real question isn’t whether Bitcoin will bounce back — it’s this: If the biggest “never-sell believer” is preparing to sell, does the entire Bitcoin narrative still hold up?